Fletcher Aaron G.L.
SEC CIK 1789490 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CGTX | COGNITION THERAPEUTICS INC | Dir, 10% | 81.2K | $2.28M | $1,083 | 8 | 2021-10-13 | 2026-06-17 |
| LTRN | Lantern Pharma Inc. | 10% | 57.5K | — | $689.1K | 3 | 2022-03-17 | 2024-05-23 |
| CUE | Cue Biopharma, Inc. | Dir | 940.0K | $4.21M | — | 2 | 2022-03-31 | 2022-05-23 |
| SWKHL | SWK Holdings Corp | Dir | 9,873 | — | — | 3 | 2021-09-30 | 2021-12-31 |
Most active insiders at CGTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Doyle John Brendan | CFO | $11.3K | — |
| 2 | Caggiano Anthony | Chief Medical Off | $11.1K | — |
| 3 | Ricciardi Lisa | CEO, Pres, Dir | $10.1K | — |
| 4 | Wallace Peggy | Dir | — | — |
| 5 | Fletcher Aaron G.L. | Dir, 10% | — | — |
| 6 | Khattar Jack A. | Dir | — | — |
| 7 | Monia Brett P | Dir | — | — |
| 8 | RICHSTONE ELLEN B | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 16:00 | 2026-06-17 | CGTX | COGNITION THERAPEUTICS INC | Fletcher Aaron G.L. | Dir, 10% | A - Grant | $0.00 | +25.0K | 81.2K | +44% | $0 | |
| D | 2025-09-23 | 2025-09-19 | CGTX | COGNITION THERAPEUTICS INC | Fletcher Aaron G.L. | Dir, 10% | M - OptEx | $0.84 | +7,729 | 56.2K | +16% | +$6,492 |
| MI | 2024-05-28 | 2024-05-23+ | LTRN | Lantern Pharma Inc. | Fletcher Aaron G.L. | 10% | S - Sale | $6.30 | -30.0K | 57.5K | -34% | -$189.1K |
| MI | 2023-12-01 | 2023-11-29 | LTRN | Lantern Pharma Inc. | Fletcher Aaron G.L. | 10% | S - Sale | $3.44 | -145.3K | 371.9K | -28% | -$500.0K |
| I | 2023-11-13 | 2023-11-08 | CGTX | COGNITION THERAPEUTICS INC | Fletcher Aaron G.L. | Dir, 10% | A - Grant | $1.05 | +500.1K | 500.1K | New | +$525.1K |
| MI | 2022-05-25 | 2022-05-23+ | CUE | Cue Biopharma, Inc. | Fletcher Aaron G.L. | Dir | P - Purchase | $3.47 | +205.0K | 940.0K | +28% | +$711.7K |
| I | 2022-04-04 | 2022-03-31 | CUE | Cue Biopharma, Inc. | Fletcher Aaron G.L. | Dir | P - Purchase | $4.76 | +735.0K | 735.0K | New | +$3.50M |
| DMI | 2022-03-21 | 2022-03-17 | LTRN | Lantern Pharma Inc. | Fletcher Aaron G.L. | 10% | X - OptEx | $160,176.01 | +95.8K | 564.0K | +20% | +$15.34B |
| AI | 2022-02-01 | 2021-10-13 | CGTX | COGNITION THERAPEUTICS INC | Fletcher Aaron G.L. | Dir, 10% | C - Cnv Deriv | — | +1.42M | 1.42M | New | — |
| 2022-01-12 | 2021-12-31 | SWKHL | SWK Holdings Corp | Fletcher Aaron G.L. | Dir | D - Sale to Iss | — | -1,363 | 9,873 | -12% | — | |
| 2022-01-03 | 2021-12-31 | SWKHL | SWK Holdings Corp | Fletcher Aaron G.L. | Dir | A - Grant | — | +250 | 11.2K | +2% | — | |
| DMI | 2021-10-15 | 2021-10-13 | CGTX | COGNITION THERAPEUTICS INC | Fletcher Aaron G.L. | Dir | C - Cnv Deriv | — | +3.69M | 755.4K | New | — |
| DMI | 2021-10-15 | 2021-10-13 | CGTX | COGNITION THERAPEUTICS INC | Fletcher Aaron G.L. | Dir | P - Purchase | $12.00 | +190.0K | 899.9K | +27% | +$2.28M |
| DI | 2021-10-15 | 2021-10-13 | CGTX | COGNITION THERAPEUTICS INC | Fletcher Aaron G.L. | Dir | S - Sale+OE | $12.00 | -90.28 | 385.2K | -0.0% | -$1,083 |
| DI | 2021-10-15 | 2021-10-13 | CGTX | COGNITION THERAPEUTICS INC | Fletcher Aaron G.L. | Dir | X - OptEx | $0.03 | +33.5K | 385.3K | +10% | +$1,005 |
| M | 2021-10-01 | 2021-09-30+ | SWKHL | SWK Holdings Corp | Fletcher Aaron G.L. | Dir | A - Grant | — | +1,613 | 11.0K | +17% | — |
Purchase Sale Sale after option exercise All abbreviations